Purpose of review High-protein intake may lead to increased intraglomerular pressure and glomerular hyperfiltration. This can cause damage to glomerular structure leading to or aggravating chronic kidney disease (CKD). Hence, a low-protein diet (LPD) of 0.6-0.8 g/kg/day is often recommended for the management of CKD. We reviewed the effect of protein intake on incidence and progression of CKD and the role of LPD in the CKD management.
INTRODUCTION
The crucial role of the kidney in amino acid and protein metabolism, including breakdown and excretion of protein metabolites heralds paramount impact of dietary protein intake on metabolic processes regulated by the kidney and on kidney function itself. A high-protein diet may cause damage to the kidney and may lead to accumulation of toxic protein metabolites, whereas a low-protein diet (LPD) offers a variety of clinical benefits in patients with renal insufficiency. However, interests and effort to adopt the merit of LPD in the management of chronic kidney disease (CKD) remain variable. This review focuses on the reasons as to why a high dietary protein intake may cause harm to the kidney, how lower protein intake may prolong kidney longevity, and why dietary protein restriction should be considered for and how it works in the management of CKD.
per day (g/kg/day), is known to induce significant alterations in renal function and kidney health [1 & ]. In contrast to dietary intake of fat and carbohydrates, higher protein intake modulates renal hemodynamics by increasing renal blood flow and elevating intraglomerular pressure leading to higher glomerular filtration rate (GFR) and more efficient excretion of protein-derived nitrogenous waste products, whereas an increase in kidney volume and weight may ensue [2] . The so-called 'glomerular hyperfiltration' that is induced by a high-protein diet has been well reported in both animal models and in different clinical studies in human study participants (Table 1) [3] [4] [5] [6] [7] [8] , and confirmed in a recent meta-analysis, including 30 randomized controlled trials (RCTs) [9] . High-protein diet associated glomerular hyperfiltration, together with a resultant increase in urinary albumin excretion, may have deleterious consequences on the kidney and other organs in the long term [1 & ]. Experimental studies have revealed that glomerular injury by an increase in intraglomerular pressure and flow can lead to progressive glomerular damage and sclerosis [2, 10] .
Hence, while the GFR may increase in the short term, kidney damage may ensue and renal function will decline with long-term exposure to high dietary protein intake. This is important in the contemporary lifestyle where a high-protein diet for weight management has gained increasing popularity.
It is not clear whether the potentially deleterious effects of high-protein intake are equally observed in people with normal kidney function when compared to those with pre-existing kidney disorders. In the 'Nurses' Health Study,' a high-protein diet was associated with a faster decline in estimated GFR in people with subnormal kidney function, but not in those with normal kidney function [11] . It was the first large-scale observational study followed up for more than 10 years about the impact of a high-protein diet on renal function in the general population. There are additional studies with conflicting results for the impact of a high-protein diet on renal function decline in the general population [12, 13] .
A recent prospective study of the general population in Singapore indicated that the impact
KEY POINTS
Protein intake in North America and other industrialized nations is higher than the recommended amounts including in CKD patients.
LPD can be used to attenuate glomerular hyperfiltration and proteinuria, which may lead to slowdown CKD progression.
LPD may facilitate the targeted delay in the initiation of dialysis and can be used to adopt incremental or infrequent dialysis.
Effort for good adherence to LPD is essential to achieve the goals.
In dialysis patients, proper amount of protein intake should be ensured to avoid PEW. of protein consumption on the risk of end-stage renal disease (ESRD) may depend on the type of protein sources [14] . Specifically, red meat intake was strongly associated with ESRD risk in a dosedependent manner, whereas other protein sources such as poultry, fish, eggs, or dairy products did not show such a deleterious association. Higher acid load induced by sulfur-containing amino acids and end products from animal protein may exert detrimental effect on renal function. Meanwhile, another community-based cohort study showed the association of high-protein intake with cardiovascular events but not with loss of kidney function [12] . Additional studies to examine these differences are warranted. Relevant data from selected observational studies are summarized in ]. Apart from inconclusive data on the effectiveness of LPD (see subsections further) and concerns about aggravation of protein-energy wasting (PEW) [2] , one of the main obstacles to the implementation of LPD is the large gap in protein intake between the amount recommended from guidelines and what is consumed contemporarily in the USA [17] . According to the 'National Health and Nutrition Examination Survey' (NHANES) between 2001 and 2008, average dietary protein intake was 1.34 g/kg ideal body weight (IBW) per day or 1.09 g/kg actual body weight (ABW) per day in the US general population [18] , which is higher than the recommended dietary allowance of protein intake for normal healthy adults (i.e., 0.8 g/kg ABW/day) [19] . There were also variabilities in protein intake depending on CKD stages, and average protein intake was 1.04 g/kg IBW/day or 0.81 g/kg ABW/day in those with advanced stages of CKD [18] .
BENEFITS OF PROTEIN RESTRICTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
LPD reduces nitrogen waste products and decreases kidney workload by lowering intraglomerular pressure, which may protect the kidneys especially in patients with decreased nephron capital and renal function. It leads to favorable metabolic effects that 
Effect of protein restriction on proteinuria and albuminuria
Urinary protein or albumin excretion, a surrogate of the progression of CKD, increases with damages in podocytes and proximal tubular cells [21] . In turn, proteinuria induces apoptosis of renal tubules and impairs podocyte regeneration, which leads to tubular atrophy and progressive renal failure ( Fig. 2 ) [22] . Protein restriction has been demonstrated to lower proteinuria by 20-50% in patients with CKD, and a linear relationship between reduction of protein intake and decrease in proteinuria is reported [23] . LPD may exert its vasoconstrictive effect at afferent arterioles, whereas the renin-angiotensin system (RAAS) inhibition treatment preferentially decreases efferent resistance. Indeed, LPD shows an additive antiproteinuric effect over the RAAS inhibition treatment [2] . Thus, the combined treatment with LPD and the RAAS blockade may be warranted to achieve lower urinary protein levels and to further reduce risk of CKD progression.
Effect of low-protein diet on the progression of chronic kidney disease
Experimental studies in the 1980s demonstrated that LPD imposed on animal models of CKD led to a greater preservation of GFR [10] . Since then, the renoprotective effect of LPD had been supported by several clinical trials [23] . However, the 'Modification of Diet in Renal Disease' (MDRD) study, which has thus far been the largest controlled trial of dietary protein management in CKD, failed to show the definite effectiveness of LPD on retarding CKD progression [2, 10] . It contributed to form a conception that dietetic therapy plays a marginal role in the management of CKD. Yet secondary analysis of the MDRD study showed that each 0.2 g/kg/day decrease in protein intake was associated with a small amelioration in GFR decline over time (1.15 ml/min/1.73 m 2 /year), and with a halved risk of renal failure or death [24] . Indeed, the relatively short period of the MDRD study and the unusually large proportion of polycystic kidney patients who often have very slow CKD progression might have reduced the study power. The renoprotective effect of LPD may be reinforced proportionally with the extent of protein restriction. A recent RCT demonstrated that very low vegetarian protein diet (VLPD, 0.3 g/kg/day) supplemented with ketoanalogs, compared with conventional LPD (0.6 g/kg/day), mitigated kidney function decline and reduced the number of patients requiring renal replacement therapy [25] . A metaanalysis of RCTs, including the MDRD study also confirmed the risk reduction of the development of ESRD by protein restriction among nondiabetic patients with CKD [26] . It is postulated that LPD prevents uremic symptoms and avoids dialysis therapy despite the small effect on kidney function decline.
Effect of low-protein diet on metabolic control
LPD is beneficial in improving metabolic acidosis in CKD. Acid is generated during metabolism of proteins, including sulfur-containing amino acids, and predialysis serum bicarbonate concentration was lower in patients with higher protein intake 
Vicious cycle
Damage to glomerulus structure FIGURE 2. Effect of high dietary protein intake on kidney.
Protein, amino acid metabolism and therapy [27] [28] [29] . There is a tendency toward acid retention with kidney function declines and resultant chronic metabolic acidosis in CKD impairs protein metabolism, increases muscle catabolism and wasting, and aggravates decline in renal function and uremic symptoms [30] . Indeed, LPD ameliorated metabolic acidosis among patients with advanced CKD. In a study of supplemented VLPD, mean serum bicarbonate levels remained less than 19 mmol/l in the control (LPD) group, whereas it increased to the normal levels in the VLPD group [25] . Interestingly, a RCT of correcting metabolic acidosis with sodium bicarbonate supplementation among patients with stage 4 CKD showed that after 2 years of study period, participants in the intervention group experienced slower decline in kidney function, much lower incidence of ESRD, and improvements in nutritional status although they increased dietary protein intake [31] .
LPD also offers better control of CKD-mineral and bone disorder (MBD). Dietary control is essential in the management of hyperphosphatemia in CKD, because dietary protein, especially animal protein, is a major source of phosphorus [32] [33] [34] . LPD, especially with plant protein, is efficacious in lowering serum phosphorus, which results in a reduction in serum levels of parathyroid hormone and fibroblast growth factor 23 [35, 36] . Although the benefits of LPD in CKD-MBD may include slowing the progression of vascular calcification and improving cardiovascular outcome [37] , it should be noted that the risk may outweigh the benefit if LPD is solely used to control hyperphosphatemia [38,39 & ]. Additionally, LPD may attenuate insulin resistance and oxidative stress, the common features that may play roles in accelerating atherosclerosis among patients with CKD [2, 40] . VLPD supplemented with ketoanalogs also ameliorated erythropoietin responsiveness [23, 41 & ]. These metabolic advantages of LPD in CKD aid better control of uremic symptoms, decrease in cardiovascular risk, and promote less use of medications leading to better adherence [42] .
CONSERVATIVE MANAGEMENT WITH LOW-PROTEIN DIET IN END-STAGE RENAL DISEASE
Less accumulation of protein waste products relieves clinical manifestations of uremia even in very late stages of CKD, and indeed LPD can be used effectively to delay the initiation of dialysis therapy [10] . Given that earlier dialysis initiation does not appear to offer any survival benefit [1 & ], conservative approaches are warranted in managing patients with advanced CKD.
A RCT among elderly patients with GFR 5-7 ml/min demonstrated that VLPD supplemented with ketoanalogs and vitamins delayed the initiation of dialysis by a mean period of 10.7 months without negative consequences. Estimated economic benefit for healthcare system based on this study was s21 180 per patient in the first year [43] . Financial savings with delayed dialysis by LPD was also confirmed in another study [44] . Delaying dialysis with LPD could also save time for maturation of arteriovenous fistula and avoid the insertion of central venous catheter [45] . Furthermore, LPD may play a role in incremental transition to dialysis therapy; once weekly dialysis combined with LPD was found beneficial compared with thrice weekly hemodialysis with respect to frequency of hospitalization, dose of erythropoietin, phosphorus binder, and cinacalcet therapy, without a significant difference in patient survival [46] . 
CONFLICTING DATA AND SAFETY ISSUES ABOUT LOW-PROTEIN DIET IN CHRONIC KIDNEY DISEASE
In spite of extensive available evidences for the benefits of LPD described above, the renoprotective effect of LPD has been debated because of conflicting reports and concerns with malnutrition. In fact, several studies including the MDRD study showed negative results regarding the effectiveness of LPD [2, 10] , and the benefit of LPD was not confirmed in diabetic patients [54
&&
,55]. Several studies of protein restriction in CKD in patients without other serious illnesses have shown acceptable safety and a low rate of malnutrition even with VLPD. A 0.6 g/kg/day of protein intake may meet protein requirements among clinically stable, nondialysis-dependent CKD patients [40] . In a 48-month RCT of LPD in patients with CKD stages 3-5, dietary intervention was given under careful monitoring for nutritional status, and only three study participants developed malnutrition [10] , suggesting that close monitoring for nutritional status was more important to avoid malnutrition rather than the amount of protein intake itself. Some studies reported preserved body composition and skeletal muscle mass and function in CKD patients on LPD [56] . [59, 60] . In the MDRD study, the LPD group, compared with the usual diet group, experienced unfavorable changes in anthropometric measurements which account for nutritional status such as decrease in body weight, body fat percentage, skinfold thickness, and arm muscle area [61] . Furthermore, although there were no differences in nutritional parameters except for 24-h urinary creatinine between the VLPD vs. LPD group in the MDRD study, the long-term follow-up study showed higher mortality risk associated with VLPD supplemented with amino acids [62] . However, the energy intakes of participants were substantially low (%22 kcal/kg/day), which may have increased the risk of malnutrition and PEW with VLPD. This is so far the only study that followed up participants with VLPD for up to 7 years. In a recent 18-month RCT comparing ketoanalogue-supplemented VLPD with LPD, participants in both groups showed average energy intakes %30 kcal/kg IBW/day and preserved nutritional status [25] . Although the VLPD group showed a lower risk of ESRD compared with the LPD group, studies with longer follow-ups are necessary to evaluate the safety underlying VLPD.
THE CHALLENGE OF ADHERENCE TO LOW-PROTEIN DIET
Despite the established benefits of LPD in CKD management, adherence to LPD is a key element to gain its renoprotective effect. Although psychosocial factors, such as knowledge, attitude, and support, are among the most important determinants of adherence [10] , successful adherence was hardly predictable [41 & ]. Good patient-physician communication, self-monitoring of protein intake, and periodic feedback by the dietitian strengthens adherence through improved recognition of the importance of diet [63] . Education with simplified diet approaches could also assist in robust adherence [64] [65] [66] . In a RCT with CKD stage 3 patients, a renal nutrition education program, including individual classes, hands-on sessions about food types, and recipe distribution improved adherence to LPD [67] . Better knowledge about a patient's preference for food types and continuous effort to find new solutions for better tolerability would be essential for successful dietary treatment [68] . Given the high frequency of poor adherence with dietary protein restriction in some CKD management centers, there has been criticism against the role of LPD in the realworld clinical practice. In a meta-analysis of 13 RCTs, the mean of protein intake in the restricted group was 0.68 g/kg/day, which was higher than target values and marginally below the recommended protein intake in the general population [69] . Indeed, even 0.1-0.2 g/kg/day reduction in protein intake from baseline appears to result in significant metabolic improvement and longer preservation of kidney health [2] . The VLPD may offer incremental renal protection and beneficial metabolic effects compared with LPD despite a more challenging adherence and somewhat higher risk of PEW (Fig. 1) [70] . We believe some reduction in dietary protein intake from baseline is warranted across virtually all stages of CKD but the protein intake target range should be individualized, for example, we suggest less than 1.0 g/kg IBW/day for nonproteinuric CKD stages 1 and 2 such as in those after nephrectomy with a solitary kidney or elderly people with stage 3b and very slow progression, and 0.6-0.8 g/kg IBW/day for patients with estimated GFR less than 45 mg/ml/1.73 m 2 BSA or proteinuria. Good adherence to LPD is defined as an actual intake within AE20% of the prescribed target range in 80% of the time [1 & ]. It should be noted again that adherence to adequate energy intake (i.e., 30-35 kcal/kg ABW/day) is also essential for the success of protein restriction, especially with more healthy and complex carbohydrates and mono and polyunsaturated fats [71] .
NUTRITIONAL ASSESSMENT IN LOW-PROTEIN DIET
Protein and energy requirements vary with clinical conditions and across severity of disease, and actual intake could also be affected by psychosocial aspects and comorbid conditions. Therefore, frequent periodic follow-up visits, for example, every 3-4 months, for monitoring dietary intake and nutritional status is essential in the implementation of LPD. To verify if actual protein intake is in the prescribed range, the amount of protein intake should be periodically evaluated preferably by urinary nitrogen appearance (UNA) via serial 24-h urine collections [1 & ]. Dietary intake can be assessed with dietary recalls or interviews, and food frequency questionnaires [65] . One caveat is that dietary protein intake is overestimated by UNAbased calculation if patients are on hypercatabolic states, including malnutrition, inflammatory conditions, postoperative period, and burns. Because such patients would appear 'nonadherent' to LPD even if they actually follow the prescribed protein intake, careful monitoring of both disease conditions and nutritional status together with other diet assessment tools is necessary before reinforcing protein restriction.
Physical measurements such as body weight and anthropometrics [72, 73] , or biochemical parameters such as transthyretin, cholesterol, and normalized protein nitrogen appearance provide additional data on patient nutritional status [2, [74] [75] [76] . However, it should be noted that in the MDRD study, the VLPD group, compared with the LPD group, did not show any significant difference in these nutritional parameters except for 24-h urinary creatinine despite the increased mortality risk in the followup study in VLPD but not LPD [62] . Further studies are still necessary to develop a sensitive method to detect inadequate nutrient intake of either protein or energy.
ESSENTIAL AMINO ACID AND KETOANALOG SUPPLEMENTED VERY LOW-PROTEIN DIET
To attain proper nutritional status and avoid PEW, nutritional supplementation with essential amino acids (EAAs) and ketoanalogs has been proposed primarily for VLPD [41 & ]. EAAs need to be obtained from food, because they cannot be generated in the body. Meanwhile, ketoanalogs, formed by transamination of EAAs except lysine and threonine, can be utilized through their conversion to respective EAAs without providing nitrogen products [39 & ]. Potential benefits of EAAs and ketoanalogs supplementation include maintaining protein-energy status without an increase in nitrogen waste products; reducing phosphorus and acid load given no phosphorus in purified EAA or their ketoanalogs; and decreasing protein degradation and enhancing protein synthesis [39 & ]. However, it can be argued that more than 25% less protein intake than recommended dietary allowance in the general population (given the <0.6 g/kg ABW/day is the lowest protein requirement to avoid negative nitrogen balance) on a long-term basis might eventually compromise metabolic balance and survival through gradually deteriorating nutritional status if patients may suffer from hypercatabolic conditions such as infections. Such considerations have led to the emergence of a camp in the field of renal nutrition representing the opinion that even a protein intake of 0.6 g/kg/day needs to be supplemented by EAAs or ketoanalogs [19] . Indeed in both LPD and VLPD, at least 50% of the dietary protein intake should be provided by high biologic value proteins [24] .
Although the efficacy of ketoanalogs combined with VLPD, compared with standard LPD, for retarding the progression of CKD was not significant in the MDRD study, it was observed in other studies, including several RCTs and meta-analyses [2, 26, 38] . Supplemented VLPD with ketoanalogs and EAAs also had benefits for better metabolic control in hyperphosphatemia and anemia [38] . Further studies are required to explore how to combine protein restriction and supplementation for minimizing the risk of malnutrition while maximizing the benefits of LPD.
PROTEIN INTAKE IN MAINTENANCE DIALYSIS PATIENTS
Dialysis treatment may stimulate protein catabolism, which aggravates PEW in ESRD patients. In a recent study, whole-body and skeletal muscle metabolism appeared to increase during hemodialysis treatment, resulting in the greater net loss of muscle protein [58 & ]. Guidelines recommend much higher protein intake (1.2-1.4 g/kg IBW/day) in ESRD patients treated with dialysis than in predialysis CKD patients [17, 32] , because dialysis itself is sufficient to correct uremic symptoms and metabolic derangements without LPD, and proper protein intake should be assured to avoid aggravation of PEW caused by loss of nutrients and hypermetabolism during dialysis treatment [58 & ,77] . Low dietary protein intake is associated with higher morbidity, hospitalization, and mortality in hemodialysis patients [78] . Interestingly, elements of overnutrition such as increased BMI and high serum cholesterol levels, which are deleterious in the general population, are paradoxically protective in dialysis patients, which is known as 'obesity paradox' or 'reverse epidemiology' [79] . Strict diet restrictions may cause unfavorable outcome in dialysis patients. Careful relaxation for dietary restrictions and adoption of more balanced diet regimen with individualized approach should be considered in patients treated with dialysis [80 & ,81] .
CONCLUSION
The aim of LPD for handling accumulation of protein waste products conservatively and delaying the need for dialysis treatment has been hampered by the fear of PEW. Implementation of LPD as proper dietary regimen is recommended to retard decline of GFR and initiation of dialysis. A multidirectional approach including dietary interventions should be considered to ensure the best outcome for CKD patients.
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